학술논문
A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease
Document Type
Article
Author
Source
In: Pediatric Research . (Pediatric Research, August 2011, 70(2):186-191)
Subject
Language
English
ISSN
00313998
15300447
15300447